erdasporine B
type: Concept
broader: secondary amino compound

CD532
type: Concept
broader: secondary amino compound

6-hydroxypseudooxynicotine
type: Concept
broader: secondary amino compound

propafenone
type: Concept
broader: secondary amino compound

salumycin
type: Concept
broader: secondary amino compound

2-{[2-(2-chlorophenyl)-2-hydroxyethyl]amino}-N-[(2-fluorophenyl)methyl]acetamide
type: Concept
broader: secondary amino compound

gilteritinib
type: Concept
broader: secondary amino compound

abediterol
type: Concept
broader: secondary amino compound

N-(2-[(2-aminoethyl)(methyl)amino]-5-{[3-cyano-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-5-yl]amino}phenyl)acetamide
type: Concept
broader: secondary amino compound

gefitinib
type: Concept
broader: secondary amino compound

3-[(4-bromophenyl)amino]-3-(4-methoxyphenyl)-1-phenylpropan-1-one
type: Concept
broader: secondary amino compound

caldopentamine
type: Concept
broader: secondary amino compound

(-)-vincadifformine
type: Concept
broader: secondary amino compound

cytisine
type: Concept
broader: secondary amino compound

methyl N-methylanthranilate
type: Concept
broader: secondary amino compound

coelenterazine h dioxetanone
type: Concept
broader: secondary amino compound

N-{2'-[(4-fluorophenyl)amino]-4,4'-bipyridin-2-yl}-4-methoxycyclohexanecarboxamide
type: Concept
broader: secondary amino compound

methyl blue free acid
type: Concept
broader: secondary amino compound

fluazinam
type: Concept
broader: secondary amino compound

CZC-25146
type: Concept
broader: secondary amino compound

(R)-tetrahydropapaverine
type: Concept
broader: secondary amino compound

ZM 323881
type: Concept
broader: secondary amino compound

metachromin S
type: Concept
broader: secondary amino compound

robenacoxib
type: Concept
broader: secondary amino compound

palbociclib
type: Concept
broader: secondary amino compound

validoxylamine B
type: Concept
broader: secondary amino compound

trandolapril
type: Concept
broader: secondary amino compound

benzonatate
type: Concept
broader: secondary amino compound

AS1842856
type: Concept
broader: secondary amino compound

Src Inhibitor-1
type: Concept
broader: secondary amino compound

pamapimod
type: Concept
broader: secondary amino compound

3_STAR
type: ConceptGroup
member: secondary amino compound

2-methoxy-N-[3-[4-[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]anilino]-6-quinazolinyl]prop-2-enyl]acetamide
type: Concept
broader: secondary amino compound

ergometrine
type: Concept
broader: secondary amino compound

2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl]amino}-2-(propan-2-yl)pentanenitrile
type: Concept
broader: secondary amino compound

diisopropanolamine
type: Concept
broader: secondary amino compound

cadabicine sulfate
type: Concept
broader: secondary amino compound

N,N'-[disulfanediyldi(ethane-2,1-diyl)]bis[2-(1H-indol-3-yl)ethan-1-amine]
type: Concept
broader: secondary amino compound

guvacine
type: Concept
broader: secondary amino compound

N-(4-nitrophenyl)-3-oxovalidamine
type: Concept
broader: secondary amino compound

cinacalcet
type: Concept
broader: secondary amino compound

CHIR 99021
type: Concept
broader: secondary amino compound

3-(methylaminomethyl)indole
type: Concept
broader: secondary amino compound

amineptine
type: Concept
broader: secondary amino compound

bis(7)-tacrine
type: Concept
broader: secondary amino compound

CGP 78608
type: Concept
broader: secondary amino compound

hoerhammericine
type: Concept
broader: secondary amino compound

1-(4-methoxyphenyl)-2-{[4-(4-nitrophenyl)butan-2-yl]amino}ethanol
type: Concept
broader: secondary amino compound

Hoffman's violet free base
type: Concept
broader: secondary amino compound

albumycin
type: Concept
broader: secondary amino compound

NSC 23766
type: Concept
broader: secondary amino compound

retaspimycin
type: Concept
broader: secondary amino compound

N-methylleucine
type: Concept
broader: secondary amino compound

LY3009120
type: Concept
broader: secondary amino compound

CBL0137
type: Concept
broader: secondary amino compound

spiraprilat
type: Concept
broader: secondary amino compound

AKI00000020a
type: Concept
broader: secondary amino compound

BCI-215
type: Concept
broader: secondary amino compound

TMC-52C
type: Concept
broader: secondary amino compound

chanoclavine-I aldehyde
type: Concept
broader: secondary amino compound

validamycin A
type: Concept
broader: secondary amino compound

ketamine
type: Concept
broader: secondary amino compound

albuterol
type: Concept
broader: secondary amino compound

mefuparib
type: Concept
broader: secondary amino compound

betahistine
type: Concept
broader: secondary amino compound

chloroquine
type: Concept
broader: secondary amino compound

argatroban
type: Concept
broader: secondary amino compound

N-(2-methoxyethyl)-4-{[6-(pyridin-4-yl)quinazolin-2-yl]amino}benzamide
type: Concept
broader: secondary amino compound

alpha-(methylamino)isobutyric acid
type: Concept
broader: secondary amino compound

PD-153035
type: Concept
broader: secondary amino compound

N-desmethylvenlafaxine
type: Concept
broader: secondary amino compound

ceratamine A
type: Concept
broader: secondary amino compound

desipramine
type: Concept
broader: secondary amino compound

N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine
type: Concept
broader: secondary amino compound

N(4)-{2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinolin-8-yl}pentane-1,4-diamine
type: Concept
broader: secondary amino compound

D-octopine
type: Concept
broader: secondary amino compound

fenamic acid
type: Concept
broader: secondary amino compound

panobinostat
type: Concept
broader: secondary amino compound

N-[1-(3,5-dimethylphenoxy)propan-2-yl]-6-(2-fluoropropan-2-yl)-1,3,5-triazine-2,4-diamine
type: Concept
broader: secondary amino compound

ICI 118551
type: Concept
broader: secondary amino compound

ML228
type: Concept
broader: secondary amino compound

N-methyl-beta-alanine
type: Concept
broader: secondary amino compound

SGC-CK2-1
type: Concept
broader: secondary amino compound

propylhexedrine
type: Concept
broader: secondary amino compound

(-)-demecolcine
type: Concept
broader: secondary amino compound

saracatinib
type: Concept
broader: secondary amino compound

8-(6-aminohexylamino)-cAMP
type: Concept
broader: secondary amino compound

3-[(3-aminopropyl)amino]-4-hydroxybenzoic acid
type: Concept
broader: secondary amino compound

alminoprofen
type: Concept
broader: secondary amino compound

organic amino compound
type: Concept
narrower: secondary amino compound

2,5-bis(2-hydroxyethylamino)-3,6-diaziridinylbenzoquinone
type: Concept
broader: secondary amino compound

melagatran
type: Concept
broader: secondary amino compound

baeocystin
type: Concept
broader: secondary amino compound

xylazine
type: Concept
broader: secondary amino compound

4'-hydroxydiclofenac
type: Concept
broader: secondary amino compound

TMC-52D
type: Concept
broader: secondary amino compound

sertraline
type: Concept
broader: secondary amino compound

anilazine
type: Concept
broader: secondary amino compound

5-hydroxydiclofenac
type: Concept
broader: secondary amino compound

pyrimethanil
type: Concept
broader: secondary amino compound

ximelagatran
type: Concept
broader: secondary amino compound

fenfluramine
type: Concept
broader: secondary amino compound

4-[2-[[1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]phenol
type: Concept
broader: secondary amino compound

(2S,3R,2'R)-nadolol
type: Concept
broader: secondary amino compound

spirit blue base
type: Concept
broader: secondary amino compound

fenoterol
type: Concept
broader: secondary amino compound

(+)-minovincinine
type: Concept
broader: secondary amino compound

5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)-1,3-benzothiazol-6-yl hydrogen sulfate
type: Concept
broader: secondary amino compound

N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide
type: Concept
broader: secondary amino compound

pibutidine
type: Concept
broader: secondary amino compound

5,5,7,12,12,14-hexamethyl-1,4,8,11-tetrazacyclotetradecane
type: Concept
broader: secondary amino compound

nilotinib
type: Concept
broader: secondary amino compound

ABT-737
type: Concept
broader: secondary amino compound

GDC-0623
type: Concept
broader: secondary amino compound

TMC-52A
type: Concept
broader: secondary amino compound

(2R,3S,2'R)-nadolol
type: Concept
broader: secondary amino compound

ethirimol
type: Concept
broader: secondary amino compound

iproheptine
type: Concept
broader: secondary amino compound

isoprenaline
type: Concept
broader: secondary amino compound

3'-hydroxy-4'-methoxydiclofenac
type: Concept
broader: secondary amino compound

validoxylamine A
type: Concept
broader: secondary amino compound

Trientine hydrochloride
type: Concept
broader: secondary amino compound

secodine
type: Concept
broader: secondary amino compound

ZM447439
type: Concept
broader: secondary amino compound

E3040 glucuronide
type: Concept
broader: secondary amino compound

ICR 340 (free base)
type: Concept
broader: secondary amino compound

erdasporine A
type: Concept
broader: secondary amino compound

19-O-acetylhoerhammericine
type: Concept
broader: secondary amino compound

1-(tert-butylamino)-3-[(2-methyl-1H-indol-4-yl)oxy]propan-2-yl benzoate
type: Concept
broader: secondary amino compound

4'-O-methylnorbelladine
type: Concept
broader: secondary amino compound

torasemide carboxylic acid
type: Concept
broader: secondary amino compound

sapitinib
type: Concept
broader: secondary amino compound

imidapril
type: Concept
broader: secondary amino compound

ethyl 2-(methylamino)-1-phenylcyclohex-3-ene-1-carboxylate
type: Concept
broader: secondary amino compound

onosmin A
type: Concept
broader: secondary amino compound

AZD3463
type: Concept
broader: secondary amino compound

terpendole J
type: Concept
broader: secondary amino compound

norflurazon
type: Concept
broader: secondary amino compound

pseudoephedrine
type: Concept
broader: secondary amino compound

N-{4-[2-ethyl-1-(1,2,4-triazol-1-yl)butyl]phenyl}-1,3-benzothiazol-2-amine
type: Concept
broader: secondary amino compound

thalicpureine
type: Concept
broader: secondary amino compound

florbetaben ((18)F)
type: Concept
broader: secondary amino compound

ML240
type: Concept
broader: secondary amino compound

mepanipyrim
type: Concept
broader: secondary amino compound

3'-hydroxydiclofenac
type: Concept
broader: secondary amino compound

plerixafor
type: Concept
broader: secondary amino compound

(2R,3S,2'S)-nadolol
type: Concept
broader: secondary amino compound

liproxstatin-1
type: Concept
broader: secondary amino compound

chanoclavine-I
type: Concept
broader: secondary amino compound

5-amino-1-anilinoimidazole-4-carbonitrile
type: Concept
broader: secondary amino compound

sotalol
type: Concept
broader: secondary amino compound

1-(2-chlorophenyl)-2-isopropylaminoethanol
type: Concept
broader: secondary amino compound

SRS16-86
type: Concept
broader: secondary amino compound

1-[4-carboxy-2-(3-pentylamino)phenyl]-5,5-bis(hydroxymethyl)pyrrolidin-2-one
type: Concept
broader: secondary amino compound

praliciguat
type: Concept
broader: secondary amino compound

N-(3-methoxyphenyl)quinazolin-4-amine
type: Concept
broader: secondary amino compound

SGC-CLK-1
type: Concept
broader: secondary amino compound

N(2)-methylguanine
type: Concept
broader: secondary amino compound

guvacoline
type: Concept
broader: secondary amino compound

amocarzine
type: Concept
broader: secondary amino compound

4-(6-ethoxypyrazolo[1,5-b]pyridazin-3-yl)-N-(3-methoxyphenyl)pyrimidin-2-amine
type: Concept
broader: secondary amino compound

AZD-1152
type: Concept
broader: secondary amino compound

N,N'-bis(diphenylmethyl)ethane-1,2-diamine
type: Concept
broader: secondary amino compound

cobimetinib
type: Concept
broader: secondary amino compound

atomoxetine
type: Concept
broader: secondary amino compound

N-methyl-1-(5-pyridin-3-ylfuran-2-yl)methanamine
type: Concept
broader: secondary amino compound

acridine red 3B free base
type: Concept
broader: secondary amino compound

4-(6-ethoxypyrazolo[1,5-b]pyridazin-3-yl)-N-[3-(morpholin-4-yl)phenyl]pyrimidin-2-amine
type: Concept
broader: secondary amino compound

N-(1-benzylpiperidin-4-yl)-2-(pyridin-3-yl)quinazolin-4-amine
type: Concept
broader: secondary amino compound

5-(2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl)-2-methoxybenzenesulfonamide
type: Concept
broader: secondary amino compound

indacaterol
type: Concept
broader: secondary amino compound

binimetinib
type: Concept
broader: secondary amino compound

methyl 3-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}propanoate
type: Concept
broader: secondary amino compound

carvedilol
type: Concept
broader: secondary amino compound

sarpagine
type: Concept
broader: secondary amino compound

(2S,3R,2'S)-nadolol
type: Concept
broader: secondary amino compound

HG-9-91-01
type: Concept
broader: secondary amino compound

N(6)-(6-aminohexyl)-cAMP
type: Concept
broader: secondary amino compound

PA-16-0081C
type: Concept
broader: secondary amino compound

mephedrone
type: Concept
broader: secondary amino compound

(2-Methylpropyl)(propyl)amine
type: Concept
broader: secondary amino compound

4',5-dihydroxydiclofenac
type: Concept
broader: secondary amino compound

purmorphamine
type: Concept
broader: secondary amino compound

3-(phenethylamino)-butan-2-one
type: Concept
broader: secondary amino compound

2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide
type: Concept
broader: secondary amino compound

pevonedistat
type: Concept
broader: secondary amino compound

pexidartinib
type: Concept
broader: secondary amino compound

BDA-366
type: Concept
broader: secondary amino compound

onosmin B
type: Concept
broader: secondary amino compound

tesevatinib
type: Concept
broader: secondary amino compound

iminodiacetonitrile
type: Concept
broader: secondary amino compound

dizocilpine
type: Concept
broader: secondary amino compound

2,6-dihydroxypseudooxynicotine
type: Concept
broader: secondary amino compound

N(1),N(8)-bis(coumaroyl)spermidine
type: Concept
broader: secondary amino compound

WAY-316606
type: Concept
broader: secondary amino compound

G-573
type: Concept
broader: secondary amino compound

D617
type: Concept
broader: secondary amino compound

4-{2-[(2-hydroxybenzyl)amino]ethyl}-2,5-dimethoxybenzonitrile
type: Concept
broader: secondary amino compound

TG101209
type: Concept
broader: secondary amino compound

1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-N-[4-(5-thioxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)phenyl]-1,4-dihydroquinoline-3-carboxamide
type: Concept
broader: secondary amino compound

N-[cyano(2-thienyl)methyl]-4-ethyl-2-(ethylamino)-1,3-thiazole-5-carboxamide
type: Concept
broader: secondary amino compound

diclofenac
type: Concept
broader: secondary amino compound

hydroxychloroquine
type: Concept
broader: secondary amino compound

(S)-(+)-4-(5-carboxypentyl)methamphetamine
type: Concept
broader: secondary amino compound

SB 415286
type: Concept
broader: secondary amino compound

UCL 1684
type: Concept
broader: secondary amino compound

N-deethylaconine
type: Concept
broader: secondary amino compound

N,N'-bis[3-(ethylamino)propyl]-2-butene-1,4-diamine
type: Concept
broader: secondary amino compound

6,8-difluoro-4-(pyridin-3-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline
type: Concept
broader: secondary amino compound

4-(1-hydroxy-2-{[4-(4-hydroxyphenyl)butan-2-yl]amino}ethyl)phenol
type: Concept
broader: secondary amino compound

2-(hydroxymethyl)-4-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)phenol
type: Concept
broader: secondary amino compound

tanespimycin
type: Concept
broader: secondary amino compound

spectinomycin
type: Concept
broader: secondary amino compound

2-(6-aminohexylamino)-cAMP
type: Concept
broader: secondary amino compound

methyl N-(2,6-dichlorobenzyl)-3-[2-(2,6-dichlorophenyl)-6-quinolyl]alaninate
type: Concept
broader: secondary amino compound

E3040
type: Concept
broader: secondary amino compound

2-(6-methylpyridin-2-yl)-N-(pyridin-4-yl)quinazolin-4-amine
type: Concept
broader: secondary amino compound

vatalanib
type: Concept
broader: secondary amino compound

Src Inhibitor-5
type: Concept
broader: secondary amino compound

N-[2-hydroxy-5-(1-hydroxy-2-{[1-(4-methoxyphenyl)propan-2-yl]amino}ethyl)phenyl]formamide
type: Concept
broader: secondary amino compound

selumetinib
type: Concept
broader: secondary amino compound

(1S,2R)-5-methoxy-1-methyl-2-(propylamino)tetralin
type: Concept
broader: secondary amino compound

SMER 28
type: Concept
broader: secondary amino compound

2-(methylamino)acetaldehyde
type: Concept
broader: secondary amino compound

GGTI-2133 free base
type: Concept
broader: secondary amino compound

7-nitrobenzoxadiazole-6-aminohexanoic acid
type: Concept
broader: secondary amino compound

N-(2-hydroxyethyl)-beta-alanine
type: Concept
broader: secondary amino compound

R24
type: Concept
broader: secondary amino compound

pyriminostrobin
type: Concept
broader: secondary amino compound

tolfenamic acid
type: Concept
broader: secondary amino compound

vilanterol
type: Concept
broader: secondary amino compound

lumiracoxib
type: Concept
broader: secondary amino compound

chrysopine
type: Concept
broader: secondary amino compound

GSK2879552
type: Concept
broader: secondary amino compound

PD158780
type: Concept
broader: secondary amino compound

bitolterol
type: Concept
broader: secondary amino compound

TMC-52B
type: Concept
broader: secondary amino compound

alangimarckine
type: Concept
broader: secondary amino compound

bupropion
type: Concept
broader: secondary amino compound

5-chloro-N-{1-[4-(difluoromethoxy)phenyl]propyl}-6-methylpyrimidin-4-amine
type: Concept
broader: secondary amino compound

5-(methylamino)-2-phenyl-4-[3-(trifluoromethyl)phenyl]furan-3(2H)-one
type: Concept
broader: secondary amino compound

N(1),N(12)-diethylspermine
type: Concept
broader: secondary amino compound

N,O-didesmethylvenlafaxine
type: Concept
broader: secondary amino compound

norbelladine
type: Concept
broader: secondary amino compound

1-(1,3-benzodioxol-5-yl)-N-ethylpropan-2-amine
type: Concept
broader: secondary amino compound

methyl 5-(hydroxymethyl)pyrrolidine-2-carboxylate
type: Concept
broader: secondary amino compound

glafenine
type: Concept
broader: secondary amino compound

diclofenac beta-D-glucosiduronic acid
type: Concept
broader: secondary amino compound

flutemetamol ((18)F)
type: Concept
broader: secondary amino compound

rucaparib
type: Concept
broader: secondary amino compound

L-BMAA
type: Concept
broader: secondary amino compound

pavettamine
type: Concept
broader: secondary amino compound

trandolaprilat
type: Concept
broader: secondary amino compound

ceritinib
type: Concept
broader: secondary amino compound

5-[1-hydroxy-2-(isopropanylamino)ethyl]benzene-1,3-diol
type: Concept
broader: secondary amino compound

N,O-dimethyltyramine
type: Concept
broader: secondary amino compound

N-(2-aminoethyl)-1-aziridine-ethanamine
type: Concept
broader: secondary amino compound

D-nopaline
type: Concept
broader: secondary amino compound

validoxylamine A 7'-phosphate
type: Concept
broader: secondary amino compound

erdasporine C
type: Concept
broader: secondary amino compound

6-{4-[(4-ethylpiperazin-1-yl)methyl]phenyl}-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
type: Concept
broader: secondary amino compound

N-methyl-D-aspartic acid
type: Concept
broader: secondary amino compound

pacein
type: Concept
broader: secondary amino compound

GSK3-XIII
type: Concept
broader: secondary amino compound

cangrelor
type: Concept
broader: secondary amino compound

3-epi-fagomine
type: Concept
broader: secondary amino compound

practolol
type: Concept
broader: secondary amino compound

9-cyclopentyl-N(8)-(2-fluorophenyl)-N(2)-(4-methoxyphenyl)-9H-purine-2,8-diamine
type: Concept
broader: secondary amino compound

imidaprilat
type: Concept
broader: secondary amino compound

Bis-(2-decyloxy-ethyl)-amine
type: Concept
broader: secondary amino compound

N-pyrazin-2-yl-N(2)-{1-[2-(1H-pyrazol-1-yl)phenyl]ethyl}glycinamide
type: Concept
broader: secondary amino compound

N-benzylquinazolin-4-amine
type: Concept
broader: secondary amino compound

N(2)-[3-methoxy-4-(morpholin-4-yl)phenyl]-N(4)-(quinolin-3-yl)pyrimidine-2,4-diamine
type: Concept
broader: secondary amino compound

idelalisib
type: Concept
broader: secondary amino compound

loline
type: Concept
broader: secondary amino compound

3-[(4-anilinophenyl)diazenyl]benzene-1-sulfonic acid
type: Concept
broader: secondary amino compound

(R)-DRF053
type: Concept
broader: secondary amino compound

tubulosine
type: Concept
broader: secondary amino compound

amodiaquine
type: Concept
broader: secondary amino compound

4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol
type: Concept
broader: secondary amino compound

2,2'-iminobis[1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)ethanol]
type: Concept
broader: secondary amino compound

N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine
type: Concept
broader: secondary amino compound

N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide
type: Concept
broader: secondary amino compound

ent-pavettamine
type: Concept
broader: secondary amino compound

desmethyldoxepin
type: Concept
broader: secondary amino compound

spirapril
type: Concept
broader: secondary amino compound

colterol
type: Concept
broader: secondary amino compound

stepharine
type: Concept
broader: secondary amino compound

4-methyl-N-[3-(morpholin-4-yl)phenyl]-3-[3-(piperidin-4-yl)-1,2-benzoxazol-6-yl]benzamide
type: Concept
broader: secondary amino compound

THZ531
type: Concept
broader: secondary amino compound

noribogaine
type: Concept
broader: secondary amino compound

STM2457
type: Concept
broader: secondary amino compound

N-(3-fluorophenyl)-2-(pyridin-4-yl)quinazolin-4-amine
type: Concept
broader: secondary amino compound

dacomitinib
type: Concept
broader: secondary amino compound

N-(3-{[2-(2-fluorophenyl)quinazolin-4-yl]amino}phenyl)acetamide
type: Concept
broader: secondary amino compound

L-3-aminosuccinimide
type: Concept
broader: secondary amino compound

atenolol acid
type: Concept
broader: secondary amino compound

CHZ868
type: Concept
broader: secondary amino compound

1-(2,4-difluorophenyl)-6-fluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
type: Concept
broader: secondary amino compound

AZT-1152
type: Concept
broader: secondary amino compound

acridine half-mustard
type: Concept
broader: secondary amino compound

SCH51344
type: Concept
broader: secondary amino compound

validamycin B
type: Concept
broader: secondary amino compound

metoprolol
type: Concept
broader: secondary amino compound

bupirimate
type: Concept
broader: secondary amino compound

isometheptene
type: Concept
broader: secondary amino compound

4'-hydroxy torasemide
type: Concept
broader: secondary amino compound

actinodaphnine
type: Concept
broader: secondary amino compound

N-(4-methylphenyl)-2-(pyridin-4-yl)quinazolin-4-amine
type: Concept
broader: secondary amino compound

SRS11-92
type: Concept
broader: secondary amino compound

{2-[(isopropylamino)methyl]-7-nitro-1,2,3,4-tetrahydroquinolin-6-yl}methanol
type: Concept
broader: secondary amino compound

mannopine
type: Concept
broader: secondary amino compound

2-benzylidene-3-(cyclohexylamino)indan-1-one
type: Concept
broader: secondary amino compound

N-methylglucamine
type: Concept
broader: secondary amino compound

norajmaline
type: Concept
broader: secondary amino compound

nisoxetine
type: Concept
broader: secondary amino compound

LDC4297
type: Concept
broader: secondary amino compound

chlordiazepoxide
type: Concept
broader: secondary amino compound

phenylephrine
type: Concept
broader: secondary amino compound

olodaterol
type: Concept
broader: secondary amino compound

LRRK2-IN-1
type: Concept
broader: secondary amino compound

1,17-Diamino-4,9,13-triazaheptadecane
type: Concept
broader: secondary amino compound

erlotinib
type: Concept
broader: secondary amino compound

iminoctadine
type: Concept
broader: secondary amino compound

4-(methylamino)antipyrine
type: Concept
broader: secondary amino compound

alvespimycin
type: Concept
broader: secondary amino compound

indolmycin
type: Concept
broader: secondary amino compound

amoscanate
type: Concept
broader: secondary amino compound

3-chloro-N-[trans-4-(methylamino)cyclohexyl]-N-[3-(pyridin-4-yl)benzyl]-1-benzothiophene-2-carboxamide
type: Concept
broader: secondary amino compound

p-aminodiphenylamine
type: Concept
broader: secondary amino compound

N-{3-[(2-phenylquinazolin-4-yl)amino]phenyl}acetamide
type: Concept
broader: secondary amino compound

N-(1-benzylpyrrolidin-3-yl)-5,6-dimethylthieno[2,3-d]pyrimidin-4-amine
type: Concept
broader: secondary amino compound

Benzylhydrochlorothiazide
type: Concept
broader: secondary amino compound

N(1),N(8)-bis-(dihydrocaffeoyl)spermidine
type: Concept
broader: secondary amino compound

torasemide
type: Concept
broader: secondary amino compound

reversine
type: Concept
broader: secondary amino compound

meclofenamic acid
type: Concept
broader: secondary amino compound

clenbuterol
type: Concept
broader: secondary amino compound

pendimethalin
type: Concept
broader: secondary amino compound

monomethylphosphatidylethanolamine 36:2
type: Concept
broader: secondary amino compound

N-ethylasparagine
type: Concept
broader: secondary amino compound

N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydropyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide
type: Concept
broader: secondary amino compound

ASP-3026
type: Concept
broader: secondary amino compound

methyl 5-(hydroxymethyl)pyrrolidine-3-carboxylate
type: Concept
broader: secondary amino compound

metipranolol
type: Concept
broader: secondary amino compound

solabegron
type: Concept
broader: secondary amino compound

acebutolol
type: Concept
broader: secondary amino compound

octamylamine
type: Concept
broader: secondary amino compound

PD 0325901
type: Concept
broader: secondary amino compound

5-[(1-phenylcyclohexyl)amino]pentanoic acid
type: Concept
broader: secondary amino compound

10-hydroxycoronaridine
type: Concept
broader: secondary amino compound

1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol
type: Concept
broader: secondary amino compound

iodocyanopindolol
type: Concept
broader: secondary amino compound

cyclopentamine
type: Concept
broader: secondary amino compound

dasatinib (anhydrous)
type: Concept
broader: secondary amino compound

secondary amino compound
type: Concept
narrower: pexidartinib
narrower: propafenone
narrower: amocarzine
narrower: Trientine hydrochloride
narrower: 5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)-1,3-benzothiazol-6-yl hydrogen sulfate
narrower: N-(2-hydroxyethyl)-beta-alanine
narrower: atenolol acid
narrower: iproheptine
narrower: 2-(6-aminohexylamino)-cAMP
narrower: 8-(6-aminohexylamino)-cAMP
narrower: LDC4297
narrower: TMC-52B
narrower: methyl 5-(hydroxymethyl)pyrrolidine-3-carboxylate
narrower: ergometrine
narrower: 10-hydroxycoronaridine
narrower: ticagrelor
narrower: N-(1-benzylpyrrolidin-3-yl)-5,6-dimethylthieno[2,3-d]pyrimidin-4-amine
narrower: ICI 118551
narrower: selumetinib
narrower: N(6)-(6-aminohexyl)-cAMP
narrower: N(1),N(8)-bis-(dihydrocaffeoyl)spermidine
narrower: 5-amino-1-anilinoimidazole-4-carbonitrile
narrower: nisoxetine
narrower: 4-{2-[(2-hydroxybenzyl)amino]ethyl}-2,5-dimethoxybenzonitrile
narrower: (2-Methylpropyl)(propyl)amine
narrower: N(1),N(12)-diethylspermine
narrower: caldopentamine
narrower: N-(4-methylphenyl)-2-(pyridin-4-yl)quinazolin-4-amine
narrower: bitolterol
narrower: AMG-925
narrower: chanoclavine-I
narrower: N-methyl-beta-alanine
narrower: 2-(methylamino)acetaldehyde
narrower: secodine
narrower: 2-(6-methylpyridin-2-yl)-N-(pyridin-4-yl)quinazolin-4-amine
narrower: TMC-52A
narrower: N-methyl-1-(5-pyridin-3-ylfuran-2-yl)methanamine
narrower: mannopine
narrower: liproxstatin-1
narrower: metipranolol
narrower: SCH51344
narrower: amodiaquine
narrower: 4'-hydroxy torasemide
narrower: pseudoephedrine
narrower: (-)-vincadifformine
narrower: N,O-dimethyltyramine
narrower: colterol
narrower: ML228
narrower: 4-(1-hydroxy-2-{[4-(4-hydroxyphenyl)butan-2-yl]amino}ethyl)phenol
narrower: (-)-minovincinine
narrower: noribogaine
narrower: N-(4-nitrophenyl)-3-oxovalidamine
narrower: mepanipyrim
narrower: erlotinib
narrower: betahistine
narrower: N-benzylquinazolin-4-amine
narrower: E3040 glucuronide
narrower: N,O-didesmethylvenlafaxine
narrower: iminoctadine
narrower: tesevatinib
narrower: 2,2'-iminobis[1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)ethanol]
narrower: methyl 5-(hydroxymethyl)pyrrolidine-2-carboxylate
narrower: ceratamine A
narrower: 9-cyclopentyl-N(8)-(2-fluorophenyl)-N(2)-(4-methoxyphenyl)-9H-purine-2,8-diamine
narrower: 4',5-dihydroxydiclofenac
narrower: N-methylglucamine
narrower: L-3-aminosuccinimide
narrower: HG-10-102-01
narrower: spectinomycin
narrower: 5-(methylamino)-2-phenyl-4-[3-(trifluoromethyl)phenyl]furan-3(2H)-one
narrower: practolol
narrower: purmorphamine
narrower: sapitinib
narrower: stepharine
narrower: 2-{[2-(2-chlorophenyl)-2-hydroxyethyl]amino}-N-[(2-fluorophenyl)methyl]acetamide
narrower: 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl]amino}-2-(propan-2-yl)pentanenitrile
narrower: bupirimate
narrower: albumycin
narrower: albuterol

ticagrelor
type: Concept
broader: secondary amino compound

AMG-925
type: Concept
broader: secondary amino compound

(-)-minovincinine
type: Concept
broader: secondary amino compound

HG-10-102-01
type: Concept
broader: secondary amino compound

3-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}propanoic acid
type: Concept
broader: secondary amino compound

(S,S)-2,5-di-(p-hydroxybenzyl)piperazine
type: Concept
broader: secondary amino compound

ezogabine
type: Concept
broader: secondary amino compound

mansouramycin A
type: Concept
broader: secondary amino compound

nocardicin G
type: Concept
broader: secondary amino compound

enasidenib
type: Concept
broader: secondary amino compound

coelenterazine dioxetanone
type: Concept
broader: secondary amino compound

3-(phenethylamino)-butan-2-one(1+)
type: Concept
broader: secondary amino compound

finafloxacin
type: Concept
broader: secondary amino compound

PFE-PKIS 18
type: Concept
broader: secondary amino compound

desmethylranitidine
type: Concept
broader: secondary amino compound

N(1),N(8)-bis(caffeoyl)spermidine
type: Concept
broader: secondary amino compound

mefenamic acid
type: Concept
broader: secondary amino compound

Iproheptine hydrochloride
type: Concept
broader: secondary amino compound

N,N'-diphenyl-1,4-phenylenediamine
type: Concept
broader: secondary amino compound

navitoclax
type: Concept
broader: secondary amino compound

secondary amine
type: Concept
broader: secondary amino compound

4-hydroxymethamphetamine
type: Concept
broader: secondary amino compound

CGP 12177
type: Concept
broader: secondary amino compound

momelotinib
type: Concept
broader: secondary amino compound

N(1),N(8)-bis(sinapoyl)-spermidine
type: Concept
broader: secondary amino compound

2,3,8,9-tetramethoxy-5,6,11,12-tetrahydro-5,11-epiminodibenzo[a,e][8]annulene
type: Concept
broader: secondary amino compound

N-(2,6-dimethylindan-1-yl)-6-(1-fluoroethyl)-1,3,5-triazine-2,4-diamine
type: Concept
broader: secondary amino compound

cyprodinil
type: Concept
broader: secondary amino compound

aceclofenac
type: Concept
broader: secondary amino compound

hydroxy torasemide
type: Concept
broader: secondary amino compound

Durazol blue 4R (acid form)
type: Concept
broader: secondary amino compound

diphenylamine
type: Concept
broader: secondary amino compound

dysidine
type: Concept
broader: secondary amino compound

CHIR-98014
type: Concept
broader: secondary amino compound

zinolol
type: Concept
broader: secondary amino compound

8-demethyl-8-(methylamino)riboflavin
type: Concept
broader: secondary amino compound

alprenolol
type: Concept
broader: secondary amino compound

17-O-acetylnorajmaline
type: Concept
broader: secondary amino compound

2-methylamino-1-phenylpropan-1-one
type: Concept
broader: secondary amino compound

osimertinib
type: Concept
broader: secondary amino compound

alpha-putrescinylthymine
type: Concept
broader: secondary amino compound

varenicline
type: Concept
broader: secondary amino compound